Dolby Laboratories (DLB) Financials

$61.96

$0.04 (0.06%)

As on 04-Sep-2026 16:19EDT

Market cap

$5,804 Mln

Revenue (TTM)

$1,354 Mln

P/E Ratio

26.4

P/B Ratio

2.2

Div. Yield

2.3 %

Income Statement ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Operating Revenue	1,354.36	1,349.13	1,273.72	1,009.18	1,253.79	1,281.26
Cost of Revenue	167.78	160.13	140.50	117.01	141.36	130.03
Gross Profit	1,186.58	1,189.00	1,133.23	892.17	1,112.43	1,151.23
Operating Expenses	941.34	924.04	868.52	656.46	895.21	810.47
Operating Profit (EBIT)	245.24	264.96	264.71	219.25	217.23	340.76
Other Income	--	--	--	--	9.07	10.60
Profit before Tax	276.77	303.49	312.48	241.02	215.28	354.51
Provision for Tax	48.77	46.99	48.16	-49.28	31.38	36.69
Profit after Tax (Net Income)	226.18	255.02	261.83	191.47	184.09	310.23
Minority Interest	-1.83	-1.47	-2.49	-0.99	0.19	7.60
Consolidated Profit	102.66	255.02	261.83	200.66	184.09	310.23

Liabilities ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Shareholder's Funds	2,583.55	2,622.56	2,477.16	2,355.10	2,246.18	2,597.98
Minority Interest	-1.83	--	--	--	4.84	6.25
Non-Current Liabilities	147.56	158.02	225.88	200.15	173.64	202.94
Current Liabilities	416.33	437.79	417.84	422.23	277.52	315.72
Total Liabilities	3,572.93	3,227.76	3,130.61	2,994.56	2,702.17	3,122.89

Assets ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Non-Current Assets	1,830.56	1,839.50	1,936.20	1,506.76	1,391.28	1,362.39
Current Assets	1,326.04	1,388.26	1,194.42	1,487.80	1,310.89	1,760.50
Total Assets	3,572.93	3,227.76	3,130.61	2,994.56	2,702.17	3,122.89
Total Debt*	47.45	38.88	46.99	50.65	50.94	72.12
Net Current Assets	909.71	950.47	776.58	1,065.58	1,033.38	1,444.78

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Cash From Operating Activities	--	472.20	327.25	282.07	318.58	447.75
Cash Flow from Investing Activities	--	-10.59	-286.29	54.21	-295.94	-44.91
Cash from Financing Activities	--	-247.24	-287.81	-194.01	-610.56	-252.52
Net Cash Inflow / Outflow	--	--	--	--	-587.92	153.05

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Adjusted EPS ($)	2.36	2.63	2.71	1.96	1.87	2.97
Cash EPS ($)	2.35	3.65	3.61	2.94	2.92	4.05
Adjusted Book Value ($)	27.59	27.08	25.65	24.11	22.81	24.89
Dividend per Share ($)	2.33	--	--	--	--	--
Cash Flow per Share ($)	--	4.88	3.39	2.89	3.24	4.29
Free Cash Flow per Share ($)	--	4.44	3.08	2.66	2.63	3.77

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
ROCE (%)	--	9.84	10.62	8.14	7.41	11.97
ROE (%)	8.67	10.00	10.84	8.32	7.60	12.33
ROA (%)	6.32	8.02	8.55	6.72	6.32	10.24
EBIT Margin (%)	19.90	20.75	24.53	21.73	17.17	27.67
Net Margin (%)	16.70	18.90	20.56	18.97	14.58	24.01
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Revenue Growth (%)	0.55	0.06	0.26	-0.20	-0.02	0.10
EBIT Growth (%)	-13.93	-10.40	42.52	1.84	-39.27	47.89
Net Profit Growth (%)	-14.63	-2.60	36.74	4.01	-40.66	34.09
EPS Growth (%)	-13.35	-0.03	0.38	0.05	-0.37	0.32
Book Value Growth (%)	1.69	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Price / Earnings	26.37	27.48	28.23	40.43	34.85	29.61
Price / Book Value	2.24	2.67	2.98	3.29	2.86	3.54
Dividend Yield (%)	2.33	--	--	--	--	--
EV/EBITDA	14.15	16.76	17.16	31.18	17.71	17.73
Close Price ($)	52.58	72.37	76.53	79.26	65.15	88.00
High Price ($)	77.00	89.66	90.06	91.02	96.85	104.74
Low Price ($)	50.73	68.24	66.35	61.55	65.04	64.07
Market Cap ($ Cr)	5,803.72	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Debt to Equity	--	0.01	0.02	0.02	0.02	0.03
Short term debt to equity ratio	0.00	0.00	0.00	0.01	0.01	0.01
Current Ratio	3.19	3.17	2.86	3.52	4.72	5.58
Quick Ratio	3.11	3.10	2.78	3.44	4.64	5.54
Interest Coverage	22.97	--	9.17	1,361.78	546.39	740.11

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Debtors to sales (%)	36.33	37.94	40.27	44.03	33.47	32.38
Asset Turnover	0.38	0.42	0.42	0.35	0.43	0.42
Receivable days	--	138.73	137.26	156.36	121.57	107.85
Inventory Days	--	73.16	90.15	92.35	44.59	51.29
Payable days	--	40.17	49.79	54.77	41.28	42.69
Cash Conversion Cycle	--	171.72	177.61	193.94	124.88	116.44

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)